Variable | 28-day mortality | P-value | |
---|---|---|---|
No (n = 418) | Yes (n = 86) | ||
Baseline characteristics | Â | Â | Â |
 Age (years) | 67.75 (12.51) | 73.88 (11.27) |  < 0.001 |
 Gender, n (%) |  |  | 0.002 |
  Male | 261 (62.44%) | 38 (44.19%) |  |
  Female | 157 (37.56%) | 48 (55.81%) |  |
 Height (m) | 1.70 (0.11) | 1.66 (0.10) | 0.002 |
 Weight (Kg) | 83.21 (20.57) | 75.39 (21.88) | 0.002 |
 Distribution of mortality days and length of stays | 7.47 (4.60–12.02) | 3.75 (1.87–7.44) |  < 0.001 |
Laboratory test | Â | Â | Â |
 Hemoglobin (g/dl) | 12.10 (2.18) | 11.56 (2.34) | 0.042 |
 Glucose (mmol/L) | 7.90 (6.40–10.70) | 8.40 (6.90–13.57) | 0.077 |
 Creatinine (mg/dl) | 1.10 (0.82–1.55) | 1.33 (0.90–1.99) | 0.006 |
 BUN (mg/dl) | 20.00 (15.00–31.00) | 25.50 (17.00–37.00) |  < 0.001 |
 Lactate (mmol/L) | 1.57 (1.10–2.40) | 2.45 (1.70–5.50) |  < 0.001 |
 PH | 7.36 (0.10) | 7.33 (0.12) | 0.026 |
 AG | 13.19 (5.20) | 13.96 (5.47) | 0.216 |
 RDW | 14.44 (1.87) | 14.67 (1.91) | 0.234 |
Scoring systems | Â | Â | Â |
 APACHE IV score | 54.00 (41.00–70.00) | 72.50 (61.00–90.00) |  < 0.001 |
 Braden skin score | 16.43 (3.37) | 16.23 (3.20) | 0.586 |
Vital signs | Â | Â | Â |
 SBP (mmHg) | 120.36 (23.38) | 114.68 (23.97) | 0.051 |
 DBP (mmHg) | 70.34 (15.20) | 65.57 (15.21) | 0.011 |
 RR (beats/minute) | 20.09 (5.29) | 21.90 (6.09) | 0.006 |
Comorbidities, n (%) | Â | Â | Â |
 Diabetes |  |  | 0.093 |
  No | 293 (70.10%) | 68 (79.07%) |  |
  Yes | 125 (29.90%) | 18 (20.93%) |  |
 AMI-location |  |  | 0.715 |
  Non-Q | 185 (44.26%) | 39 (45.35%) |  |
  Anterior | 75 (17.94%) | 15 (17.44%) |  |
  Anterolateral | 29 (6.94%) | 7 (8.14%) |  |
  Anteroseptal | 14 (3.35%) | 1 (1.16%) |  |
  Inferior | 95 (22.73%) | 19 (22.09%) |  |
  Lateral | 14 (3.35%) | 5 (5.82%) |  |
  Posterior | 6 (1.44%) | 0 (0.00%) |  |
Past history, n (%) | Â | Â | Â |
 Prior AF |  |  |  < 0.001 |
  No | 390 (93.30%) | 69 (80.23%) |  |
  Yes | 28 (6.70%) | 17 (19.77%) |  |
 Prior CHF |  |  | 0.287 |
  No | 359 (85.89%) | 70 (81.40%) |  |
  Yes | 59 (14.11%) | 16 (18.60%) |  |
 Prior hypertension |  |  | 0.594 |
  No | 191 (45.69%) | 42 (48.84%) |  |
  Yes | 227 (54.31%) | 44 (51.16%) |  |
 Prior stroke |  |  | 0.651 |
  No | 388 (92.82%) | 81 (94.19%) |  |
  Yes | 30 (7.18%) | 5 (5.81%) |  |
 Prior CABG |  |  | 0.939 |
  No | 385 (92.11%) | 79 (91.86%) |  |
  Yes | 33 (7.89%) | 7 (8.14%) |  |
 PCI within 24 h |  |  | 0.587 |
  No | 119 (28.47%) | 22 (25.58%) |  |
  Yes | 299 (71.53%) | 64 (74.42%) |  |
 Thrombolytics within 24 h |  |  | 0.908 |
  No | 328 (78.47%) | 67 (77.91%) |  |
  Yes | 90 (21.53%) | 19 (22.09%) |  |
 Myocardial infarction during past 6 months |  |  | 0.632 |
  No | 410 (98.09%) | 85 (98.84%) |  |
  Yes | 8 (1.91%) | 1 (1.16%) |  |
 Cardiac arrest |  |  | – |
  No | 418 (82.90%) | 86 (17.00%) |  |
  Yes | 0 | 0 |  |
 Shock |  |  | – |
  No | 418 (82.90%) | 86 (17.00%) |  |
  Yes | 0 | 0 |  |